Symphony IL-6 Assay
Sepsis Triage & Monitoring
Key Facts
About Bluejay Diagnostics
Bluejay Diagnostics is a clinical-stage, pre-revenue company focused on revolutionizing point-of-care diagnostics with its automated Symphony platform. Its core mission is to accelerate clinical decision-making by providing quantitative biomarker results at the bedside within 20 minutes, directly addressing critical delays in conditions like sepsis. The company's near-term strategy is singularly focused on achieving regulatory clearance and commercialization of its lead Symphony IL-6 assay for sepsis triage. Long-term success hinges on leveraging the adaptable Symphony platform to develop a menu of follow-on assays, though it faces significant challenges including regulatory hurdles, commercialization execution, and intense competition in the diagnostics space.
View full company profile